DZNep may directly target putative cancer stem cells in biliary tract cancer cells by inhibition of PRC2
C Mayr, A Wagner, A Stöcklinger, M Jakab, R Illig, M Pichler, F Berr, D Neureiter, T Kiesslich · Zeitschrift für Gastroenterologie · 2014 · Heft 08
Bibliografische Angaben
Zusammenfassung
Introduction: The Polycomb Repressive Complex 2 (PRC2) silences genes via trimethylation of histone 3 at lysine 27 (H3K27me3). This type of epigenetic silencing represents one mechanism of malignant cells to gain and maintain stem cell-like status. It was shown that 3-Deazaneplanocin-A (DZNep), an S-adenosyl-L-homocysteine hydrolase inhibitor, is able to disturb the PRC2 complex and to reduce H3K27me mediated gene silencing. Aim & Methods: The aim of this project is to investigate the effect of DZNep on viability, anchorage-independent sphere formation, gene expression and proliferation of eight biliary tract ca…